$4.48
3.94% yesterday
NYSE, Nov 25, 10:15 pm CET
ISIN
US58463J3041
Symbol
MPW

Medical Properties Trust Target price 2024 - Analyst rating & recommendation

Medical Properties Trust Classifications & Recommendation:

Buy
9%
Hold
55%
Sell
36%

Medical Properties Trust Price Target

Target Price $4.94
Price $4.48
Potential
Number of Estimates 8
8 Analysts have issued a price target Medical Properties Trust 2025 . The average Medical Properties Trust target price is $4.94. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 11 analysts: 1 Analysts recommend Medical Properties Trust to buy, 6 to hold and 4 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medical Properties Trust stock has an average upside potential 2025 of . Most analysts recommend the Medical Properties Trust stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 871.80 1,037.38
43.49% 18.99%
EBITDA Margin 78.53% 87.48%
9.35% 11.39%
Net Margin -64.03% -98.83%
209.72% 54.35%

8 Analysts have issued a sales forecast Medical Properties Trust 2024 . The average Medical Properties Trust sales estimate is

$1.0b
Unlock
. This is
61.76% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.4b 115.96%
Unlock
, the lowest is
$932m 45.36%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $872m 43.49%
2024
$1.0b 18.99%
Unlock
2025
$1.0b 3.34%
Unlock
2026
$1.1b 9.32%
Unlock
2027
$1.1b 0.07%
Unlock
2028
$1.0b 6.73%
Unlock

6 Analysts have issued an Medical Properties Trust EBITDA forecast 2024. The average Medical Properties Trust EBITDA estimate is

$907m
Unlock
. This is
603.78% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$1.2b 862.46%
Unlock
, the lowest is
$770m 497.02%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $685m 48.78%
2024
$907m 32.54%
Unlock
2025
$786m 13.41%
Unlock
2026
$882m 12.26%
Unlock
2027
$997m 13.02%
Unlock

EBITDA Margin

2023 78.53% 9.35%
2024
87.48% 11.39%
Unlock
2025
78.36% 10.43%
Unlock
2026
80.47% 2.69%
Unlock
2027
90.89% 12.95%
Unlock

1 Analyst has issued a net profit forecast Medical Properties Trust 2024 . The average Medical Properties Trust net profit estimate is

$-1.0b
Unlock
. This is
61.53% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-1.0b 61.53%
Unlock
, the lowest is
$-1.0b 61.53%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-558m 162.00%
2024
$-1.0b 83.66%
Unlock
2025
$64.5m 106.29%
Unlock
2026
$159m 146.91%
Unlock

Net Margin

2023 -64.03% 209.72%
2024
-98.83% 54.35%
Unlock
2025
6.44% 106.52%
Unlock
2026
14.53% 125.62%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -0.93 -1.71
162.00% 83.87%
P/E negative
EV/Sales 11.21

1 Analysts have issued a Medical Properties Trust forecast for earnings per share. The average Medical Properties Trust <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.71
Unlock
. This is
61.49% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-1.71 61.49%
Unlock
, the lowest is
$-1.71 61.49%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-0.93 162.00%
2024
$-1.71 83.87%
Unlock
2025
$0.11 106.43%
Unlock
2026
$0.27 145.45%
Unlock

P/E ratio

Current -1.01 98.73%
2024
-2.62 159.41%
Unlock
2025
41.67 1,690.46%
Unlock
2026
16.88 59.49%
Unlock

Based on analysts' sales estimates for 2024, the Medical Properties Trust stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

11.21
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 18.14 97.60%
2024
11.21 38.18%
Unlock
2025
11.60 3.45%
Unlock
2026
10.61 8.53%
Unlock
2027
10.60 0.07%
Unlock
2028
11.37 7.21%
Unlock

P/S ratio

Current 4.19 106.11%
2024
2.59 38.18%
Unlock
2025
2.68 3.45%
Unlock
2026
2.45 8.53%
Unlock
2027
2.45 0.07%
Unlock
2028
2.63 7.21%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today